Participants:18–64 years · 65+ years
Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drugNo placebo

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

Study of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ribociclib

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Malignant peritoneal neoplasm+2

Recruiting

Registered drugNo placebo

Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Colon cancer stage III+1

Recruiting

Registered drugNo placebo

Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Ovarian epithelial cancer

Recruiting

Registered drug

Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Letrozole

Contact Research Centre

Find therapies in clinical trials near you

33 trials match your criteria

Chronic obstructive pulmonary disease

Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

Acute respiratory failure

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Coeliac disease

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Chronic obstructive pulmonary disease

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Idiopathic pulmonary fibrosis

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Non-small cell lung cancer+1

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Breast cancer+1

Study of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib

Chronic obstructive pulmonary disease

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Breast cancer+1

A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

Malignant peritoneal neoplasm+2

Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

Colon cancer stage III+1

Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

Ovarian epithelial cancer

Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.